HuMax-HepC

Genmab is seeking to out-license HuMax-HepC, an IND-ready antibody for the prevention of HCV reinfection in liver transplant recipients.

Non-Confidential Brochure is available.

A confidential data package is available after execution of a suitable non-disclosure agreement (CDA). Interested parties may request a one way CDA or a two way CDA.

Registered users may access the Confidential Data Room here.